Markets
Out of balance
Perfectly balanced? (Getty Images)
PREMIA DONNA

You’re getting paid nothing for risking money in the stock market, per the equity risk premium

Yeah, stocks are still on a 4% or higher earnings yield... but when bonds offer the same, what do you do?

Matt Phillips
8/1/25 7:27AM

Companies are risky. They blow up, go bankrupt, and equity holders tend to get paid last when that happens.

That’s why investors putting their money in stocks, rather than safe government bonds, have typically required a sweetener — known by some as the equity risk premium — to reward their bravery.

But that extra return has now vanished, the latest data point confirming the speculative character of the stock market at the moment.

First things first: what is the equity risk premium (ERP), exactly? It’s a method of comparing potential returns on bonds, measured in yields, with the potential return on stocks, represented by something called “earnings yields.” Earnings yields reimagine a share as a kind of bond, with expected earnings as the “yield.” If a stock costs $100 and is expected to make $4 in profit, it’s got a 4% earnings yield.

(Full disclosure: there are many variants of ERP. We’re going to use one of the most basic, subtracting the 10-year nominal Treasury yield from the earnings yield on the S&P 500.)

In theory, when earnings yields are higher than Treasury yields, that extra cushion should coax people to buy stocks. But at roughly zero, the list of reasons to buy the market, at least as far theoretical fundamentals are concerned, gets very short.

But who needs rational reasons right now! This gets at another way to think about ERP: as a gauge of investor risk appetite. As NYU professor Aswath Damodaran, the godfather of valuation geeks, explained in a recent paper, “​As investors become more risk averse, equity risk premiums will climb, and as risk aversion declines, equity risk premiums will fall.”

In other words, the vanishing risk premium — along with meme stocks, options trading, outperforming unprofitable companies, and passing references to “euphoria” from Wall Street analysts — is another data point on the speculative brouhaha now unfolding. 

That doesn’t mean a stock market crash is imminent. But at some point, market risk seemingly high and rewards low, the safety of bonds might start to look a little more attractive.

More Markets

See all Markets
markets

GameStop can’t stop winning, on track for longest streak of gains since 2022

Unless we jinx it, GameStop is poised for its longest winning streak since 2022, with shares up 3% as of 2:04 p.m. ET.

The video game and collectibles retailer hasn’t posted a down day since September 4 and is poised for its eighth consecutive day of gains. Shares are up nearly 18% over this period, versus a 1.6% advance for the S&P 500.

The bulk of these gains came in the wake of the company’s stellar second-quarter earnings report, which exceeded expectations on the top and bottom lines as well as marking the fifth consecutive quarter of positive operating cash flow generation for the first time in its history.

Including this one, the company has posted eight or more consecutive days of gains on 25 occasions during its history as a publicly traded company.

Its last seven-session winning streak came in mid-July of last year, about a month after Keith Gill (aka Roaring Kitty) disappeared from the scene after his brief reappearance, as part of a relatively violent market rotation into small-cap stocks.

markets

Nio surges to an 11-month high following an upgrade from UBS ahead of its new SUV launch

Chinese EV maker Nio is climbing for the fourth straight trading day, following an upgrade from UBS to buy from neutral. Nio’s nearly 7% jump propelled the stock to its highest level since last October.

UBS also bumped its price target for Nio up to $8.50, a 37% hike.

Nio will begin deliveries of its new ES8 SUV this weekend, priced to compete with Tesla’s Model Y. Last week, the EV maker said it planned to raise up to $1 billion on a share offering.

According to UBS analyst Paul Gong, Nio’s latest products “could further attract consumers after the US $1 billion equity offerings strengthened visibility on its healthy operations.”

markets

Moderna is up on the release of positive results for reformulated Covid vaccine

Moderna rose on Tuesday after it announced encouraging trial results for its next COVID-19 vaccine.

The data from its phase 4 clinical trial showed the 2025-26 formula of its COVID-19 vaccine, which targets a new variant and was recently approved by the FDA with some limitations, produced a strong immune response among people ages 12 through 64. Covid vaccine sales account for virtually all of Modernas revenue.

The company has had a tumultuous year as the Trump administration makes moves to limit who is able to access the vaccine. Last month, the FDA limited approval for the coronavirus vaccine to higher-risk populations; previously, anyone older than 6 months was eligible for it.

markets

Rivian climbs as it breaks ground on a $5 billion EV plant that could produce 200,000 vehicles a year by 2028

EV tax credits may be ending this month, but Rivian’s still optimistic about future demand.

The electric vehicle maker on Tuesday broke ground on its delayed $5 billion Georgia plant that it says will be able to produce 200,000 vehicles per year by 2028. (For comparison, Rivian expects to deliver up to 46,000 EVs this year.) Its shares climbed more than 6% on the news.

The plant will create 7,500 permanent jobs once complete, according to Rivian, with the first phase of production beginning next year.

2026 also marks the planned launch year for Rivian’s R2 electric SUV, expected to start around $45,000 and compete with Tesla’s Model Y. Earlier this month, Lucid confirmed that it too would be creating a roughly $50,000 electric SUV.

If it seems like an odd time to build an EV plant, it probably is. But unlike larger rivals GM and Honda, Rivian doesn’t have the ability to scale back its EV ambitions — they’re the only vehicles the automaker produces. Last month, the company posted a steeper loss than analysts expected, losing $1.12 billion over its second quarter.

The plant will create 7,500 permanent jobs once complete, according to Rivian, with the first phase of production beginning next year.

2026 also marks the planned launch year for Rivian’s R2 electric SUV, expected to start around $45,000 and compete with Tesla’s Model Y. Earlier this month, Lucid confirmed that it too would be creating a roughly $50,000 electric SUV.

If it seems like an odd time to build an EV plant, it probably is. But unlike larger rivals GM and Honda, Rivian doesn’t have the ability to scale back its EV ambitions — they’re the only vehicles the automaker produces. Last month, the company posted a steeper loss than analysts expected, losing $1.12 billion over its second quarter.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.